Skip to main content

Hydroxychloroquine

In the US, Hydroxychloroquine (hydroxychloroquine systemic) is a member of the following drug classes: antimalarial quinolines, antirheumatics and is used to treat Dermatomyositis, Lichen Planopilaris, Lyme Disease - Arthritis, Malaria, Malaria Prevention, Rheumatoid Arthritis, Sjogren's Syndrome, Systemic Lupus Erythematosus and Undifferentiated Connective Tissue Disease.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

P01BA02

CAS registry number (Chemical Abstracts Service)

0000118-42-3

Chemical Formula

C18-H26-Cl-N3-O

Molecular Weight

336

Therapeutic Categories

Antiprotozoal agent: Antimalarial

Disease-modifying antirheumatic drug, DMARD

Chemical Name

Etanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]etylamino]-

Foreign Names

  • Hydroxychloroquinum (Latin)
  • Hydroxychloroquin (German)
  • Hydroxychloroquine (French)
  • Hidroxicloroquina (Spanish)

Generic Names

  • Hydroxychloroquine (OS: BAN)
  • Idroxiclorochina (OS: DCIT)
  • Oxychloroquine (IS)
  • Win 1258-2 (IS)
  • Hydroxychloroquine (PH: Ph. Eur. 9.3)
  • Hydroxychloroquine Sulfate (OS: BANM, JAN)
  • Hydroxychloroquine Sulfate (PH: BP 2018, Ph. Eur. 9.3, USP 41)
  • Hydroxychloroquini sulfas (PH: Ph. Eur. 9.3)

Brand Names

  • Axokine
    Rontag, Argentina
  • Dimard
    Metlen, Ecuador
  • Hidroxiplus
    Perulab, Peru
  • Hydrocad
    Cadila, India
  • Hydroquin
    Sun Pharma, Thailand
  • Ilinol
    Pharma Investi de Chile, Chile
  • Mcqs
    Molekule, India
  • Narbon
    Buxton, Argentina
  • Plaquenil
    Concordia Pharmaceuticals, United States; Sanofi Aventis, Tunisia
  • Plaquinol
    Sanofi-Aventis, Peru
  • Polireumin
    Perulab, Peru
  • Quinilen
    Royal Pharma, Chile
  • Quinoric
    Bristol Laboratories, Cyprus; Sanolabor, Slovenia
  • Reumaquin
    AC Farma, Peru
  • Supretic
    Eticos, Paraguay
  • Zy-Q
    Zydus, India
  • APO-Hydroxychloroquine
    Apotex, Australia
  • Apo-Hydroxychloroquine Sulfate
    Apotex, Hong Kong
  • Apo-Hydroxyquine
    Apotex, Canada
  • Be-easy
    Shinlon, Taiwan
  • Chloguin
    Weidar, Taiwan
  • Dimard
    Siegfried, Colombia
  • Dolquine
    Rubio, Spain
  • Evoquin
    Ivax, Argentina; Teva, Uruguay
  • Fen Le
    ZhongXi Pharmaceutical, China
  • Geniquin
    Genovate, Taiwan
  • Haloxin
    Hanlim, South Korea
  • HCQS
    IPCA, Thailand
  • Hequinel
    Arrow Pharmaceuticals, Australia
  • Hidroxicloroquina Sulfato Pharma Arte
    Pharma Arte, Paraguay
  • Hydroquine
    Minapharm, Egypt; Taiwan Biotech, Taiwan
  • Hydroxychloroquine
    Apotex, Russian Federation
  • Hydroxychloroquine AN
    Amneal Pharma, Australia
  • Hydroxychloroquine GH
    Generic Health, Australia
  • Hydroxychloroquine RBX
    Ranbaxy, Australia
  • Hydroxychloroquine sulfate
    Zentiva, United Kingdom
  • Hydroxychloroquine Sulfate
    Hikma, United States; Ipca, United States; Mylan, United States; Sandoz, United States; Teva, United States; Watson Pharmaceutical, United States; Zydus Pharma, United States
  • Hydroxychloroquine Sulfate Lenis
    LENIS, Slovenia
  • Hydroxychloroquine Sulphate P & D
    P & D, Malta
  • Hydroxychloroquine Zentiva 200mg
    Helvepharm, Switzerland
  • Hydroxychloroquinesulfaat CF
    Centrafarm, Netherlands
  • Metirel
    Pfizer, Uruguay; Rontag, Argentina
  • Mylan-Hydroxychloroquine
    Mylan Pharmaceuticals, Canada
  • Oxiklorin
    Kyung Poong, South Korea; Orion Pharma, Finland
  • Plaquenil
    Abbott Laboratories S.A., China; Dr. Fisher Farma, Netherlands; Eureco-Pharma, Netherlands; Euro Registratie, Netherlands; First Pharma, Estonia; Lex ano, Lithuania; Sanofi, Denmark; Sanofi, Ireland; Sanofi, Japan; Sanofi, Sweden; Sanofi Aventis, China; Sanofi Belgium, Belgium; Sanofi Israel, Israel; Sanofi Malta, Malta; Sanofi Romania, Romania; Sanofi Winthrop, Kuwait; Sanofi-Aventis, Argentina; Sanofi-Aventis, Australia; Sanofi-Aventis, Canada; Sanofi-Aventis, Cyprus; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Estonia; Sanofi-Aventis, France; Sanofi-Aventis, Georgia; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Iceland; Sanofi-Aventis, Italy; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Norway; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Philippines; Sanofi-Aventis, Slovakia; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan; Sanofi-Aventis Netherlands, Netherlands; Sanofi-Aventis SA, Greece; synth, Egypt
  • Plaquenil 200mg
    Sanofi Belgium, Luxembourg; Sanofi-Aventis, Switzerland
  • Plaquenil-Hydroxychloroquine sulfate
    Zentiva, United Kingdom
  • Plaquinol
    Alfa Wassermann, Portugal; Sanofi Aventis, Chile; Sanofi-Aventis, Colombia; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Paraguay; Sanofi-Aventis, Venezuela; Sanofi-Aventis Farmaceutica, Brazil
  • Polirreumin
    TRB Pharma, Argentina
  • Pro-Hydroxyquine
    Pro Doc, Canada
  • Quensyl 200mg
    Sanofi-Aventis Deutschland, Germany
  • Quinoric
    Bristol Laboratories, United Kingdom; Central Procurement & Supplies Unit, Malta
  • Reumazine
    Instituto Sanitas, Chile
  • Reuquinol
    Apsen, Brazil

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.